Cart
sales@molnova.com
BMS-986122
CAS No. 313669-88-4
BMS-986122( BMS 986122 | BMS986122 )
Catalog No. M27859 CAS No. 313669-88-4
BMS 986122 is a positive allosteric modulator of μ-opioid receptors that increases β-arrestin recruitment stimulated by endomorphin 1 in U2OS-OPRM1 human osteosarcoma cells expressing μ-opioid receptors (EC50 = 3 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 644 | In Stock |
|
| 200MG | 910 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS-986122
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS 986122 is a positive allosteric modulator of μ-opioid receptors that increases β-arrestin recruitment stimulated by endomorphin 1 in U2OS-OPRM1 human osteosarcoma cells expressing μ-opioid receptors (EC50 = 3 μM).
-
DescriptionBMS 986122 is a positive allosteric modulator of μ-opioid receptors that increases β-arrestin recruitment stimulated by endomorphin 1 in U2OS-OPRM1 human osteosarcoma cells expressing μ-opioid receptors (EC50 = 3 μM).
-
In Vitro——
-
In Vivo——
-
SynonymsBMS 986122 | BMS986122
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorFAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number313669-88-4
-
Formula Weight448.77
-
Molecular FormulaC16H15BrClNO3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (222.83 mM)
-
SMILESCOc1ccc(cc1Br)C1SCCN1S(=O)(=O)c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hui Jin Jung, et al. Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor. Bioorg Med Chem Lett. 2021 Apr 1;37:127846.
molnova catalog
related products
-
CTAP
Potent and selective μ opioid receptor antagonist (IC50 = 3.5 nM). Displays > 1200-fold selectivity over δ opioid and somatostatin receptors. Brain penetrant and active in vivo.
-
Naltrexone
A potent, competitive antagonist for μ, κ, δ, and σ-opioid receptors with Ki of 0.0825 nM, 0.509 nM, and 8.02 nM, for MOR, KOR, and DOR, respectively.
-
BAN ORL 24 dihydroch...
BAN ORL 24 is a highly potent nociceptin/orphan FQ (N/OFQ) receptor (NOP) antagonist that can be used to study neurological diseases.
